# An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

> **NCT05757570** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Alpine Immune Sciences, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Immune Thrombocytopenia
- Idiopathic Thrombocytopenic Purpura
- Warm Autoimmune Hemolytic Anemia
- Cold Agglutinin Disease

## Interventions

- **DRUG:** povetacicept

## Key facts

- **NCT ID:** NCT05757570
- **Lead sponsor:** Alpine Immune Sciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-03
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05757570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05757570, "An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05757570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*